Table of Contents
Table of Contents
Dedication
Foreword
Preface
Chapter 1. Neurobiology of Substance Use Disorders
(Ahsan Nazeer, MD, Nehdia Hashemi, MD, Nazish Imran and Muhammad Waqar Azeem, MD, Department of Psychiatry, Division of Child and Adolescent Psychiatry, Sidra Medicine, Doha, Qatar, and others)
Chapter 2. Genetics and Substance Use Disorders
(Helga V Toriello, PhD, College of Human Medicine, Michigan State University, Grand Rapids, Michigan, US)
Chapter 3. The Role of the Pediatrician and Primary Care Clinician
(Shannon W Simmons, MD, Ray Chih-Jui Hsiao, MD, and Christopher K Varley, MD, Department of Psychiatry and Behavioral Sciences, University of Washington School of Medicine, Seattle, Washington, US)
Chapter 4. The Current US Opioid Epidemic: Historical Perspective and Review of Proposed Solutions
(Yonatan Benjamin Kaplan and Gabriel Kaplan, MD, Rutgers New Jersey Medical School, Newark, New Jersey, and Behavioral Health Network, RWJBarnabas Health, West Orange, New Jersey)
Chapter 5. Psychosocial Treatments for Substance Use Disorders
(Muhammad Ather, MRCPsych, Nehdia Hashemi, MD, Ahsan Nazeer, MD, and Muhammad Waqar Azeem, MD, Department of Psychiatry, Sidra Medicine, Doha, Qatar, and others)
Chapter 6. General Pharmacotherapy Principles
(Gabriel Kaplan, MD, and Aaron Damian Kaplan, Rutgers New Jersey Medical School, Newark, New Jersey, US)
Chapter 7. Use of Pharmacologic Agents for Smoking Cessation
(Dilip R. Patel, MD, Danielle Hirsch, MD, and Kimberly Wells, Department of Pediatric and Adolescent Medicine, Western Michigan University Homer Stryker MD School of Medicine, Kalamazoo, Michigan, US)
Chapter 8. Cannabis: Current Concepts and Conundrums
(Donald E. Greydanus, MD, DrHC, Karen Randall, MD, and Maria Demma Cabral, MD, Department of Pediatric and Adolescent Medicine, Western Michigan University Homer Stryker MD School of Medicine, Kalamazoo, Michigan, US, and others)
Chapter 9. Primary Care Management of Alcohol Use and Misuse of Adolescents and Young Adults
(Angela Nash, PhD, and Oscar G Bukstein, MD, The University of Texas Health Science Center, Houston, Texas, The University of Texas, Houston, Texas and Boston Children’s Hospital, Harvard Medical School, Boston, Massachusetts, US)
Chapter 10. Opioids and Prescription Drugs
(Joseph L Calles, Jr, MD, Department of Psychiatry, Western Michigan University Homer Stryker MD School of Medicine, Kalamazoo, Michigan, US)
Chapter 11. Illicit Stimulant Use Disorders in Adolescents and Young Adults
(Marc S. Lener, MD, Sarah A. R. Anderson-Burnett, MD, PhD, Abigail R Cohen, MD, and Iliyan Ivanov, MD, Singula Institute, NY, US, and others)
Chapter 12. Hallucinogens and Date Rape Drugs
(Maria Demma Cabral, MD, Colleen Dodich, MD, and Monika Siedlarz, MD, Department of Pediatric and Adolescent Medicine, Western Michigan University School of Medicine, Kalamazoo, Michigan, US)
Chapter 13. Prenatal Drug Exposure: Maternal/Fetal Issues
(Colleen Dodich, MD, Shalin Patel, MD, Amanda Williams, MD, Arushi Tripathy and Marisha G Agana, MD, Department of Pediatric and Adolescent Medicine, Western Michigan University Homer Stryker MD School of Medicine, Kalamazoo, Michigan, US)
Chapter 14. It Is Not the Same: Issues in the Diagnosis and Treatment of Substance Abuse in Adolescent Girls
(Ruqiya Shama Tareen, MD, and Kinza Tareen, MD, Department of Psychiatry, Western Michigan University School of Medicine, Kalamazoo, Michigan and Cleveland Clinic Center for Behavioral Health, Cleveland, Ohio, US)
Chapter 15. Co-Occurring Substance Use and Psychiatric Disorders in Adolescents and Young Adults: Clinical Guidelines for Diagnosis and Treatment
(Brieana M. Rowles Marino, Aaron Ellington, PhD, Andrew Tarr, John L Hertzer, MD, Robert L. Findling, MD, and Christopher J. Hammond, MD, PhD, Department of Psychiatry and Behavioral Sciences, Johns Hopkins University, Baltimore, Maryland, US, and others)
Chapter 16. Prescription Stimulant and Other Substance Abuse in College Students
(Abigail Cohen, MD, Brandon Johnson, MD and Jeffrey H Newcorn, MD, Icahn School of Medicine at Mount Sinai, New York, US)
Chapter 17. Use of Performance Enhancing Agents by Young Athletes
(Maria Demma Cabral, MD, Dilip R. Patel MD and Donald E. Greydanus MD, DrHC, Department of Pediatric and Adolescent Medicine, Western Michigan University, Homer Stryker MD School of Medicine, Kalamazoo, Michigan, US)
Chapter 18. New Drugs of Abuse in the 21st Century
(Joseph L. Calles, Jr, MD, Department of Psychiatry, Western Michigan University Homer Stryker MD School of Medicine, Kalamazoo, Michigan, US)
Chapter 19. Estimating the Societal Burden of Substance Abuse: Advantages and Limitations of Current Methodologies
(Jonathan P. Caulkins, PhD, Anna Kasunic, and Michael A. C. Lee, Carnegie Mellon University, Pittsburgh, Pennsylvania, US)
Chapter 20. The Pros and Cons of Legalization
(Jonathan P. Caulkins, PhD, Anna Kasunic, MS, Mark Kleiman, PhD, and Michael AC Lee, Carnegie Mellon University, Pittsburgh, Pensylvania and New York University, New York, US)
About the Editors
Index
